Bispecific antibodies and CAR T cells targeting a TP53 mutation–associated neoantigen show discordant affinity requirements

Journal:

Journal of Clinical Investigation

Published:

2026-01-16

DOI:

10.1172/jci192885

Affiliations:

16

Authors:

30

Go to article

Institutions	Authors	Share
Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, United States of America (USA)	16.150000 16.150000	0.54
Johns Hopkins University (JHU), United States of America (USA)	7.233333	0.24
Lustgarten Foundation Pancreatic Cancer Research Laboratory, United States of America (USA)	6.416667	0.21
Institute for NanoBioTechnology (INBT), JHU, United States of America (USA)	0.200000	0.01
Howard Hughes Medical Institute (HHMI), United States of America (USA)	0.000000	0.00

Interested in Oncology and Carcinogenesis?